Hemorrhagic shock and encephalopathy syndrome

Elizabeth A Sekul MD (Dr. Sekul of Medical College of Georgia has no relevant financial relationships to disclose.)
Bernard Maria MD, editor. (Dr. Maria of Icahn School of Medicine at Mount Sinai and Director of Pediatric Neurology and Developmental Medicine at Goryeb Children)
Originally released February 16, 2013; last reviewed March 25, 2017; expires March 25, 2020

Overview

Hemorrhagic shock and encephalopathy syndrome (HSES) is a rare disorder that primarily affects infants less than a year of age. It is often fatal despite intensive medical care, and rarely do those who survive escape severe neurologic impairment. There are no biological markers for HSES. The diagnosis rests on the recognition of its clinical and laboratory abnormalities. The hallmarks of the disorder are abrupt onset of high fever, shock, encephalopathy, seizures, coagulopathy, and renal and hepatic dysfunction. Laboratory abnormalities, including progressive decline in hematocrit and platelets and rising transaminases and creatine phosphokinase, are noted and tend to peak in the first 36 hours. Severe acidosis is typical at presentation. Onset tends to be at night to early morning hours and more often in the winter months. Overall incidence is unknown.

Key points

 

• Hemorrhagic shock and encephalopathy syndrome typically presents acutely in infants with extremely high fever (average 41°C), encephalopathy, and shock.

 

• Laboratory abnormalities of elevated creatine phosphokinase, transaminases, and severe acidosis are initially seen, and falling hematocrit and platelet counts occur during the first week. Laboratory abnormalities tend to normalize after a week.

 

• Neurologic manifestations are severe, with seizures and cerebral edema that correlate to outcome.

 

• No biological markers exist. Bacterial cultures are negative, and if viral studies are positive, the pathogen implicated does not typically cause a severe disease process.

 

• Death occurs in approximately 50% of patients, with severe neurologic impairment occurring in the majority of survivors.

Historical note and terminology

Hemorrhagic shock and encephalopathy syndrome (HSES) was originally described by Levin and colleagues (Levin et al 1983). An initial report of 10 infants within a 12-month time frame suggested an epidemic (David and Mughal 1984), but this did not later appear to be the case. Surveillance for this syndrome was done in the mid-1980s to 1990s (Bacon and Hall 1992). It has been noted worldwide.

The content you are trying to view is available only to logged in, current MedLink Neurology subscribers.

If you are a subscriber, please log in.

If you are a former subscriber or have registered before, please log in first and then click select a Service Plan or contact Subscriber Services. Site license users, click the Site License Acces link on the Homepage at an authorized computer.

If you have never registered before, click Learn More about MedLink Neurology  or view available Service Plans.